▶ Plasmapp launches 『STERLINK Lite』 and 『ACTILINK Vortex』 at SIDEX 2023

▶ SIDEX, with the largest number of employees in history, achieved a short-term sales contract that exceeded the previous year's performance based on new products

Plasmapp (405000), a bio-plasma deep tech company, participated in the 『20th Seoul International Dental Equipment Exhibition』 (hereinafter referred to as SIDEX), which was held for 3 days from the 26th of this month.

SIDEX 2023, now in its 20th year, was held with 212 companies participating and a total of 1,030 booths.

As this is the first exhibition reopened after the COVID-19 pandemic, it was expected that at least 10,000 people, including 7,000 people who pre-registered, would visit, and the actual number of participants recorded over the two days on Friday and Saturday was 11,639.

Including the number of visitors on the third day and accompanying visitors who did not receive actual name tags, the crowd is believed to be the largest ever.

At this year's SIDEX, Plasmapp newly launched 『STERLINK Lite』, a sterilizer line-up optimized for the dental market, and 『ACTILINK Vortex』, a surface treatment machine that maximizes user convenience.

STERLINK Lite, a new sterilizer model, is optimized for sterilizing various surgical devices such as handpieces commonly used in dentistry. It is released at a lower price than competitors while maintaining the high performance of existing models and high-speed sterilization performance up to 30 times faster than competitors. It has already received a lot of attention from the market.

At this SIDEX, upon its launch, it achieved performance as expected by winning over 500 short-term contracts that will lead to sales within 2023, and was recognized as a standard for the future plasma sterilizer market.

In fact, Plasmapp, which secured more than 100% growth potential at a single exhibition compared to the previous year's domestic sterilizer sales performance (300 units), was confident that it would ‘secure the No. 1 M/S in the small sterilizer market in Korea as well.’

ACTILINK Vortex, released together with STERLINK Lite, not only enables customized plasma surface treatment for each implant brand more conveniently based on “electromagnetic plasma control technology,”

Experts believe that it is possible to provide an integrated plasma surface treatment solution for a wide range of dental medical devices used in implant surgery, including bone graft materials and prosthetics, enabling safer and more efficient treatment.

Plasmapp's ACTILINK product has been preparing various preclinical results for the past two years, and the results are expected to be announced in the first half of this year, drawing extreme attention from around the world.

In particular, in the current market situation where most surface treatment devices are unable to prove their effectiveness with data, the market believes that Plasmapp's move will be unrivaled competitiveness in the global market by securing preclinical effectiveness data for the first time in the world. .

During this SIDEX period, overseas customers, including Japan, showed great interest in ACTILINK Vortex, and in particular, Japanese doctors and company officials attracted attention by filling most of the booths during the SIDEX period.

Among these, a number of small and medium-sized local Japanese dealers, led by Company H and Company N, which are large dental distributors in Japan, formed a consortium with Plasmapp to exhibit ACTILINK Vortex and STERLINK Lite at the Kyushu and Yokohama Dental Expos in Japan in June and September of this year. A contract was signed to launch each.

In the conservative Japanese market, it is very unusual for several Japanese dental distributors to sign a contract to launch a product with such a consortium, and Japanese officials say that this contract was achieved because they were confident that it would lead to sales of at least 1,000 units in the Japanese market. It was evaluated.

Samjeong Yoon, CEO of Plasmapp, expressed his ambition, saying, “We will participate in the Japanese exhibition in June to publicize Plasmapp’s excellent product capabilities and prepare thoroughly to raise sales to the next level in the Japanese market.”

Through this SIDEX event, Plasmapp signed contracts with various implant companies and dental distributors in addition to Japanese companies.

In particular, it attracted attention by signing a large-scale supply contract worth a total of 2 billion won with Renew Medical, a domestic top-tier bone graft material production and distribution company.

Renew Medical, Korea's leading bone graft material company that handles a variety of bone materials such as synthetic bone, xenogeneic bone, and allogeneic bone used in dental treatment, cooperates with the majority of domestic implant companies and is a comprehensive company that supplies a variety of dental medical devices in addition to bone graft materials. It is a medical device company.

Renew Medical and Plasmapp expect to be able to reorganize the domestic bone graft material market through a contract that includes sterilizers and the ACTILINK solution (which can dramatically increase hydrophilicity), which increases the safety and efficiency of bone graft material surgery.

In addition, the company announced that it had secured 100% growth in domestic sales compared to the previous year by pursuing contracts with a number of implant manufacturers.

Plasmapp CEO Samjeong Yoon stayed at the SIDEX site for three days and closely analyzed the market response to this newly launched product, and said, “Based on these achievements, Plasmapp will be able to leap to the top of the domestic small sterilizer market within two years.” “We are confident that sales, which were stagnant during the first quarter due to contract conversion, will also turn upward with the product launch,” he said. “Preparations to accelerate the expansion of the global market for Plasmapp’s ACTILINK surface treatment solution will soon be completed. “Once the preclinical results from the past two years are announced, we are considering the possibility that customers who demand our products as essential goods will be redefined, independent of existing market demands,” he said, expressing his confidence and ambition for business performance in 2023.

▲ Consultation and product performance demonstration for customers who visited the Plasmapp booth at the SIDEX 2023 event, photo provided by Plasmapp